There is no single “best” pain reliever for nerve pain because the answer depends on the type of nerve damage, its location, and how your body responds to medication. But the short version: the medications that work best for most people are not the ones you’d reach for in a medicine cabinet. Standard painkillers like ibuprofen and acetaminophen are generally ineffective for nerve pain. Instead, the first-line treatments are certain antidepressants, anti-seizure medications, and topical options, all of which target the nervous system directly.
Why Regular Painkillers Don’t Work
Nerve pain is fundamentally different from the pain of a sprained ankle or a sore back. Those injuries send pain signals along healthy nerves from damaged tissue. Nerve pain comes from the nerves themselves being damaged, whether from diabetes, shingles, injury, or other causes. Because the source of the pain is different, it requires different medicine.
Ibuprofen, naproxen, and other anti-inflammatory drugs are designed to reduce inflammation at the site of tissue damage. When the nerves themselves are misfiring, there’s no inflamed tissue for these drugs to act on in a meaningful way. Pain specialists broadly agree that NSAIDs lack efficacy for neuropathic pain, yet many patients try them first because they’re familiar and available over the counter. If you’ve been taking ibuprofen for nerve pain without relief, that’s the likely explanation.
The Four Main Drug Classes That Work
Clinical guidelines recommend four categories of medication as first-line therapy for nerve pain. Most people will try one or more of these before considering anything stronger.
Anti-Seizure Medications (Gabapentinoids)
Gabapentin and pregabalin are often the first medications prescribed. They work by binding to a specific part of calcium channels on nerve cells, which reduces the release of excitatory chemical signals and calms down the overactive pain signaling that characterizes nerve damage. They also activate the body’s own descending pain-suppression pathways in the spinal cord.
Both are particularly effective for postherpetic neuralgia (nerve pain after shingles), diabetic neuropathy, and spinal cord injury pain. Most doctors try gabapentin first, then switch to pregabalin if gabapentin doesn’t provide enough relief. Pregabalin is also approved for fibromyalgia. The most common side effects for both are dizziness and drowsiness, which affect roughly 1 in 5 people taking gabapentin. Pregabalin may cause more swelling in the hands and feet.
In studies of diabetic neuropathy, gabapentin had a number needed to treat (NNT) of 3.7, meaning that for roughly every 4 patients treated, one achieves meaningful pain relief beyond what a placebo would provide. In postherpetic neuralgia, that number improves to 3.2.
SNRIs (Certain Antidepressants)
Duloxetine and venlafaxine belong to a class of antidepressants that increase levels of noradrenaline and serotonin in the nervous system. For nerve pain, the key player is noradrenaline: these drugs recruit the body’s natural descending pain-suppression pathways from the brain down through the spinal cord. They also appear to have indirect anti-inflammatory effects on nerve tissue and may engage the body’s own opioid receptor system.
Duloxetine is one of the most commonly prescribed options for diabetic neuropathy specifically, and it works regardless of whether you have depression. If your doctor suggests an antidepressant for nerve pain, it’s not because they think the pain is “in your head.” These drugs have a direct, well-understood effect on pain signaling.
Tricyclic Antidepressants
Older antidepressants like nortriptyline and amitriptyline are among the most effective nerve pain treatments on paper. Tricyclics have some of the best NNT values in the research: 2.3 for postherpetic neuralgia, 2.5 for peripheral nerve injury, and as low as 1.4 for diabetic neuropathy at optimal doses. That means they help a larger proportion of patients than gabapentinoids do.
The tradeoff is side effects. Tricyclics tend to cause dry mouth, constipation, blurred vision, drowsiness, and weight gain more often than newer options. They can also affect heart rhythm, which makes them a poor choice for some older adults. For this reason, many prescribers start with gabapentin or duloxetine and reserve tricyclics for people who don’t respond to those.
Topical Treatments
When nerve pain is concentrated in one area, topical options can provide relief without the systemic side effects of oral medications. The two main options are lidocaine patches (5% concentration) and high-concentration capsaicin patches (8%).
Lidocaine numbs the nerve endings locally. In studies of postherpetic neuralgia, about 30% of patients using lidocaine patches achieved at least a 50% reduction in pain, compared to roughly 5% with placebo patches. For people with nerve pain after shingles or localized nerve injuries, these patches can be a practical first step, especially since the most common side effect is mild skin irritation at the application site.
Capsaicin patches work differently. The concentrated capsaicin overstimulates and then desensitizes the pain-signaling nerve fibers in the skin. The application itself can be intensely uncomfortable for the first hour, but a single treatment can provide weeks of relief.
Which Type of Nerve Pain Changes the Answer
The “best” medication shifts depending on your specific condition. For trigeminal neuralgia, the sharp, electric-shock facial pain, carbamazepine is the standard treatment and often works when other nerve pain medications don’t. It has an NNT of 3.3 for diabetic neuropathy, but it’s trigeminal neuralgia where it truly stands apart as the go-to option.
For diabetic neuropathy, gabapentin, pregabalin, and duloxetine are all reasonable starting points. Tricyclics may actually be more effective based on the numbers, but their side effect profile often pushes them to second-line status in practice. For postherpetic neuralgia, gabapentinoids and tricyclics both perform well, and lidocaine patches offer a good complementary option for localized discomfort. Central pain from spinal cord injury or stroke responds best to tricyclics, with an NNT of 2.5.
What to Expect When Starting Treatment
Nerve pain medications typically aren’t like taking a painkiller and feeling better in an hour. Most require a slow dose increase over several weeks, and it can take a month or more to reach a dose that provides meaningful relief. This gradual approach minimizes side effects like dizziness and drowsiness, which are most pronounced when you first start or increase a dose.
Complete pain elimination is uncommon. A realistic goal with first-line medications is a 30% to 50% reduction in pain intensity, which for most people translates to noticeably better sleep, improved function during the day, and a more manageable baseline. Many people end up on a combination of two medications from different classes, such as gabapentin plus duloxetine, to get better coverage than either one alone provides.
If the first medication you try doesn’t work, that doesn’t mean nothing will. The different drug classes work through distinct mechanisms, so failure with one doesn’t predict failure with another. A typical treatment path involves trying two or three options, sometimes in combination, before settling on what works best for you.
Newer Options on the Horizon
In January 2025, the FDA approved suzetrigine (brand name Journavx), the first in a new class of non-opioid pain medications. It works by blocking sodium channels in the peripheral nervous system, stopping pain signals before they reach the brain. The approval was specifically for moderate to severe acute pain in adults, not chronic neuropathic pain, but the mechanism is relevant to nerve pain research. Sodium channel blockers that selectively target pain-sensing nerves have been a long-sought goal in pain medicine, and this approval signals that the pipeline for non-opioid, nerve-targeted pain treatments is finally producing results.